Richard Donovan Creative Portfolio 2024

Page 1

Valneva: Ixiaro vaccine.

Travel awareness digital and print campaign highlighting the dangers of Japenese encephalitis caused by mosquito bites in the Asia-Pacific Region.

Japanese encephalitis is a rare but potentially deadly virus found in the Asia-Pacific region Speak to your healthcare professional for information and advice
It only takes one bite

No Filter: How well are your kidneys really working?

No Filter: How well are your kidneys really working? The

Look at your kidneys with No Filter to avoid having kidneys that offer No Filter in the future. DISCOVER THE TRUTH ABOUT YOUR KIDNEY HEALTH PATIENT INFORMATION BOOKLET

Help transform chronic kidney disease management across your market with our new ‘No Filter’ campaign!

No Filter: Discover the truth about your patient’s kidney health

Don’t take your kidney health for granted.

What is chronic kidney disease (CKD) and why is it important to know the facts?

It is estimated that 9 out of 10 people with CKD don’t know they have it.2 Know your risks and safeguard

AstraZeneca: No Filter: CKD awareness campaign.

Digital and print campaign to highlight awareness of chronic kidney disease.

Included printed patient booklets and editable social media assets.

This campaign was developed
funded by AstraZeneca ©2023 AstraZeneca. All rights reserved. Z2-4063 Date of Preparation: June 2023 Date of Expiry: June 2025
and
kidneys are your body’s filtration system, and they have important jobs. They: • filter your blood, removing waste and impurities1 • regulate the nutrients that your body needs.1 Look at your kidneys with No Filter to avoid having kidneys that offer No Filter in the future. Your kidneys do not recover well from damage, so it’s especially important you do all you can to take care of them. Damage to your kidneys can lead to damage to other organs, such as your heart, which can result in serious health complications.1
1
CKD is a progressive disease that can eventually lead to kidney failure.1 This means kidney dialysis or even a transplant may be required.1 CKD ranges from Stage 1
damage/normal kidney function) to Stage 5 (kidney failure).3 Some patients with CKD don’t notice any symptoms, especially in the early stages.1 Many patients don’t realise they have CKD until their kidney disease is advanced.4 CKD RISK FACTORS3,6–8 If you have certain common conditions, such as high blood pressure, diabetes or heart disease, you could be at risk of developing CKD.3,5 CKD = chronic kidney disease.
(minimal
AGE RACE AND ETHNICITY FAMILY HISTORY DIABETES HIGH BLOOD PRESSURE HEART DISEASE OBESITY SMOKING BEYOND OUR CONTROL THROUGHTREATMENT THROUGHLIFESTYLECHANGES MODIFIABLE MODIFIABLE Make an appointment with your doctor today to discuss your kidney health. 2
your kidney health.

AstraZeneca: forxiga times magazine homepage. Digital development for client who requested a move from standard infographic pdf shared on email to a newsletter style landing page to create more engagement. Landing page and supporting pages were designed and supplied in XD enabling the client to understand the user journey.

Our leaders provide an update on our mission, and reflect on our progress in CVRM A message from our leaders April 2023 From boosting diagnostic capabilities to identify chronic kidney disease, to providing suitable treatment options, we’ve been realising success in all sorts of ways. Newly-launched SEARCH 2.0 introduces innovative solutions across the patient journey April 2023 This landmark approval ensures that AstraZeneca continues to lead the way in the cardio-renal space. AstraZeneca Turkey secure the world’s first-ever DELIVER label/HFpEF indication approval April 2023 In 2022, 22 markets went live with over 95 individual omnichannel campaigns, expanding our reach and increasing our total share of voice. Celebrating the success of our markets’ omnichannel campaigns April 2023 Our recent purchase of baxdrostat enhances our position as leaders in CVRM, ensuring we continue to propagate for cardio-renal protection. Acquisition of baxdrostat strengthens AstraZeneca’s CVRM portfolio Welcome to the Forxiga Times Magazine, your go-to source of stories from across the CVRM continuum, providing you with quarterly updates that keep you in-the-know. READ MORE READ MORE READ MORE READ MORE READ MORE April 2023 Across our markets, we have taken steps to support patients with new launches and lifecycle management plans. LOE achievements ensure AstraZeneca continues to strengthen its CVRM portfolio READ MORE April 2023 Meet the individuals who will be brining you cutting-edge, quarterly updates from International CVRM. Introducing the Forxiga Times Editorial Board READ MORE April 2023 Area Directors have selected their top three markets for the last quarter, reflecting exciting progress in 2023. AstraZeneca leaders recognise top performing markets for CVRM READ MORE Omnichannel CVRM portfolio April 2023 A ‘become the patient’ app and the Centers of Excellence are some of our novel Take CaRe of Me (TCoM) initiatives. Holistic TCoM initiatives help promote disease awareness and adoption of GDMT April 2023 Meaningful change for patients with an evolutionary step forward for diabetes care in Argentina. Presentation of iCareMe evidence helps to drive update to the National Standards for Diabetes Care in Argentina READ MORE READ MORE Take CaRe of Me iCareMe Registry Launches CaReMe Approvals CaReMe CaReMe April 2023 Edition © AstraZeneca 2023 Confidential – for internal use only From boosting diagnostic capabilities to identify chronic kidney disease, to providing suitable treatment options, we’ve been realising success in all sorts of ways. Newly-launched SEARCH 2.0 introduces innovative solutions across the patient journey This landmark approval ensures that AstraZeneca continues to lead the way in the cardio-renal space. AstraZeneca Turkey secure the world’s first-ever DELIVER label/HFpEF indication approval In 2022, 22 markets went live with over 95 individual omnichannel campaigns, expanding our reach and increasing our total share of voice. Celebrating the success of our markets’ omnichannel campaigns April 2023 Our recent purchase of baxdrostat enhances our position as leaders in CVRM, ensuring we continue to propagate for cardio-renal protection. Acquisition of baxdrostat strengthens AstraZeneca’s CVRM portfolio READ MORE READ MORE READ MORE READ MORE April 2023 Across our markets, we have taken steps to support patients with new launches and lifecycle management plans. LOE achievements ensure AstraZeneca continues to strengthen its CVRM portfolio READ MORE April 2023 Meet the individuals who will be brining you cutting-edge, quarterly updates from International CVRM. Introducing the Forxiga Times Editorial Board READ MORE Area Directors have selected their top three markets for the last quarter, reflecting exciting progress in 2023. recognise top performing markets for CVRM READ MORE CVRM portfolio April 2023 A ‘become the patient’ app and the Centers of Excellence are some of our novel Take CaRe of Me (TCoM) initiatives. Holistic TCoM initiatives help promote disease awareness and adoption of GDMT April 2023 Meaningful change for patients with an evolutionary step forward for diabetes care in Argentina. Presentation of iCareMe evidence helps to drive update to the National Standards for Diabetes Care in Argentina READ MORE READ MORE Take CaRe of Me iCareMe Registry Launches CaReMe CaReMe © AstraZeneca 2023 Confidential – for internal use only

Alpharmaxim: Dementia Action Week social campaign 2023. Motion video and flat posts to raise awareness of the cognitive and physical effects of dementia on the lives of both individuals and their loved ones.

Features AI generated images via Midjourney.

EXAMPLE ON VIMEO

What is hyperkalaemia, and what causes it?

Understanding the condition and approaching potential solutions with No Filter can protect your kidneys now and in the future

High levels of potassium in the blood may be due to kidney problems or medications that affect the body’s ability to remove potassium from the blood1

Kidneys work as a filter to remove excess potassium, which may rise to dangerous levels if the kidneys are not working properly.1 Nearly 25% of patients with advanced stages of chronic kidney disease have hyperkalaemia2

Remember: staying on a prescribed dose of heart and blood pressure medication is key to maintaining a healthy heart and kidneys

A diet rich in fruits and vegetables is also recommended to help with heart and kidney health3,4

Modifying your diet, with a focus on low-potassium foods5

Using a long-term treatment for high levels of potassium6

Discuss

your

dialysis treatment5

Here are some of our 2023 highlights!

8 International markets contributed a significant of all clinical trial participants

If you have high potassium, create a daily routine to plan and manage the diet and/or medication prescribed to you by your healthcare provider To learn

40+ 12 26 experts engaged by network countries attending the 5th quarterly CoVEEN meeting with from experts

RSV Nurse Education Programme

Combines traditional online learning platforms with interactive gamification of education content for RSV.

1,300+ 25

registered users from countries

76% to 89%

increase in awareness of disease burden and methods of disease prevention by the end of the second month

AstraZeneca: Infographic creative and production. Departmental infographics created for sharing with internal AstaZeneca comms teams on social media and email.

Docquity HCP Education Project

Leveraging Docquity, Asia’s largest digital network, to provide targeted medical education and disease awareness materials beyond Asia.

is important
prescribed References 1. National Kidney Foundation. Hyperkalemia (high potassium). https://www.kidney.org/atoz/content/what-hyperkalemia. Accessed March 2024. 2. Betts KA, Woolley JM, Mu F, et al. The prevalence of hyperkalemia in the United States. Curr Med Res Opin. 2018;34(6):971–978. 3. American Heart Association. How to eat more fruit and vegetables. 26 October 2023. https://www.heart.org/en/healthy-living/healthy-eating/add-color/how-to-eat-more-fruits-and-vegetables/. Accessed March 2024. 4. National Institute of Diabetes and Digestive and Kidney Diseases. Eating right for chronic kidney disease. October 2016. https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/eating-nutrition. Accessed March 2024. 5. American Heart Association. Hyperkalemia (high potassium). 11 July 2023. https://www.heart.org/en/health-topics/heart-failure/treatment-options-for-heart-failure/hyperkalemia-high-potassium. Accessed March 2024. 6. Healthfully. What are the dangers of high potassium? 27 July 2017. https://healthfully.com/dangers-high-potassium-5415311.html. Accessed March 2024. 7. WebMD. The right balance of diet and medication for hyperkalemia. 13 January 2023. https://www.webmd.com/a-to-z-guides/features/balanced-diet-medication-hyperkalemia. Accessed March 2024. 8. Medline Plus. High potassium level. https://medlineplus.gov/ency/article/001179.htm. Accessed March 2024. 9. Davita Kidney Care. Potassium and chronic kidney disease. https://www.davita.com/diet-nutrition/articles/basics/potassium-and-chronic-kidney-disease. Accessed March 2024. 10. The Dialysis Outcomes and Practice Patterns Study (DOPPS) Program. DOPPS practice monitor. December 2020 data. May 2021. https://www.dopps.org/DPM-HD/. Accessed March 2024. Your potassium levels may
often chronic
of hyperkalaemia.1 To get potassium
to normal, your healthcare
may choose to manage hyperkalaemia in a
severity
more about long-term solutions to living with hyperkalaemia, always consult your doctor It
that all medicines are taken as
rise, due to the sometimes serious and
nature
levels back
team
variety of ways, depending on
Adjusting medicines that you may be taking5 Adjusting
This campaign was developed and funded by AstraZeneca ©2024 AstraZeneca. All rights reserved. Z2-5131 Date of Preparation: March 2024 Date of Expiry: March 2026 Hyperkalaemia
potassium
in the blood are
than normal. This condition is commonly referred to as ‘high potassium’1 and can be confirmed with a blood test
is the name for a condition where
levels
higher
it difficult
and vegetables and low in
meat7
medication was paused or reduced due to high potassium and you need to get back on track8
any side effects
for
potassium
with
healthcare team if: Diet restrictions to manage your high potassium make
to maintain a diet rich in fruits
saturated fats and
Your
You experience
from taking medication
high
help managing high potassium between dialysis
Between dialysis treatments, potassium can rise unwanted levels,5 with almost 40% of people on dialysis still experiencing high potassium despite regular dialysis treatments
~50% Healthcare resource utilisation was highest among those with severe exacerbation Clear observation between the increase in frequency of exacerbations and lung function decline of the study population had ≥1 severe exacerbation in the last 5 years of the enrolled patients have used an average of 2-3 courses of antibiotics and oral steroids The burden of COPD exacerbations is clear SUPERNOVA Clinical Trial
You need
treatments.
~50%
Our core mission in V&I relates to providing protection for the most vulnerable and high-risk patients. Whether they are immunocompromised patients at risk of COVID-19, or pre-term babies at risk of viral infections, we continue to uncover and educate about the burden of disease. We support HCPs with patient identification and prioritisation strategies and simplify clinical decision making when it matters most.
12.4% COVID Expert Engagement Network (CoVEEN)

INTERNATIONAL WOMEN’S DAY

For International Women’s Day, Alpharmaxim is highlighting the dynamic relationships between our male and female colleagues. This is how we #EmbraceEquity with Jess and Dan…

ESSENTIAL COOPERATION

What’s fantastic is that Favi and I try to collaborate as much as possible on projects. We bounce ideas off each other exceptionally well and really value each other’s input. Our differing design thinking and perspectives offer real variety in our approach, providing clients greater depth in project output.

Our backgrounds and experiences are diverse too, as we’ve trained and worked in different countries and environments. It’s an engaging mix that provides great scope for our work together, and strengthens the wider workplace. Creative

EMBRACING DIFFERENCES

From my first conversation with Ben, I could tell that he is a very empathetic person who values talent and creativity regardless of gender or background. I was initially a little uneasy, as in previous jobs I’d mainly worked in teams led by strong women.

Ben and I established a healthy working relationship by understanding and embracing our differences, and recognising our strengths (and weaknesses) based on mutual respect and team-centred goals. This undoubtedly gives us opportunities to thrive. We have built a solid alliance founded on trust and professionalism. Senior Creative

SHARED LEARNING

Adrian and I have a working partnership that allows us both to bring our strengths to the forefront. He has been instrumental in supporting me through my first years in MedComms. He’s been a guide, sharing knowledge and helping me navigate solutions calmly and professionally, but he’s also welcomed my ideas and the different perspective and approaches I have been able to bring.

I enjoy working with Adrian as he’s great at utilising his expertise to challenge a client’s thinking, to ensure their proposed plans align with their overarching story. We work together effectively because we both want the best for our clients and the rest of our internal team.

Account Manager Robyn

Alpharmaxim: International Women’s Day campaign 2023.

Flat carousel posts including photography featuring the Alpharmaxim internal team.

Director Ben
Designer Favi

Lupin: NaMuscla Mexiletine Detail Aid. Creative front cover concepts for HCP detail Aids.

Aid MOVEMENT WHEN IT MATTERS Abbreviated Prescribing Information found on page 15 Developed and produced by Lupin Neurosciences NDM, non-dystrophic myotonia NaMuscla (mexiletine) is indicated for the symptomatic treatment of myotonia in adult patients with non-dystrophic myotonic disorders Detail Aid MOVEMENT WHEN IT MATTERS Abbreviated Prescribing Information found on page 15 Developed and produced by Lupin Neurosciences NDM, non-dystrophic myotonia NaMuscla (mexiletine) is indicated for the symptomatic treatment of myotonia in adult patients with non-dystrophic myotonic disorders Detail Aid MOVEMENT WHEN IT MATTERS Abbreviated Prescribing Information found on page 15 Developed and produced by Lupin Neurosciences NDM, non-dystrophic myotonia NaMuscla (mexiletine) is indicated for the symptomatic treatment of myotonia in adult patients with non-dystrophic myotonic disorders
Detail

Lupin: NaMuscla Mexiletine Dosage card.

A4 print and interactive digital PDF.

Patients with renal or hepatic impairment1

Dose adjustment is not required for patients with mild or moderate renal impairment. Use in patients with severe renal impairment is not recommended

Caution should be used in patients with mild or moderate hepatic impairment. In these patients, it is recommended that the dose should only be increased after at least 2 weeks of treatment. Use in patients with severe hepatic impairment is not recommended

Effects on ability to drive and use machines1

Mexiletine may have a minor influence on the ability to drive and use machines. Fatigue, confusion and blurred vision may occur following administration of mexiletine

Intake of caffeine1

Clearance of caffeine is decreased following the administration of mexiletine. Caffeine intake should be reduced during treatment with mexiletine

Smoking1

Total clearance of mexiletine is significantly increased in smokers due to induction of CYP1A2. Mexiletine dose may need to be increased if a patient starts to smoke during treatment and decreased if they stop smoking

Precautions

GIVE YOUR PATIENTS WITH NDM MOVEMENT WHEN IT MATTERS Dosage Card Developed and produced by Lupin Neurosciences NDM, non-dystrophic myotonia NaMuscla® (mexiletine) is indicated for the symptomatic treatment of myotonia in adult patients with non-dystrophic myotonic disorders NaMuscla® 1st EU licensed antimyotonic proven to: help control the disabling symptoms of myotonia in adult patients with NDM1,3,4 significantly improve patient quality of life1,4,5 provide generally well-tolerated, long-term myotonia relief 2 NDM, non-dystrophic myotonia References: 1. NaMuscla®. Summary of Product Characteristics. EU/1/18/1325/001-004. 18 December 2018; 2. Suetterlin KJ, et al. JAMA Neurol 2015;72(12):1531–1533; 3. Statland JM, et al. JAMA 2012;308(13):1357–1365; 4. NaMuscla®. European public assessment report (EPAR). EMA/931802/2018. 2018; 5. Nowak U, et al Poster presented at World Muscle Society Virtual Congress 2020, 1 October 2020. Abstract P.228 NaMuscla® is a registered trademark of Lupin Atlantis Holdings SA Lupin Neurosciences is a Specialty Division of Lupin Atlantis Holdings SA EU-NAM-2105-00003 June 2021 © Lupin Ltd. 2021. All rights reserved Each patient should be given a Patient Alert Card before initiating treatment with NaMuscla® Healthcare Professional Educational Guide and Patient Alert Cards can be requested from customerserviceLEG@lupin.com or downloaded from www.lupin-neurosciences.com For more information, please refer to the Summary of Product Characteristics, which can be accessed at https://www.ema.europa.eu/en/documents/product-information/
accessed June 2021)
namuscla-epar-product-information_en.pdf (last
for use Treatment stage Recommended cardiac evaluation1 No known cardiac abnormalities Prone to cardiac abnormalities With known cardiac abnormalities Prior to treatment initiation Detailed cardiac evaluation should be carried out to determine the cardiac tolerability of mexiletine: • ECG • 24–48-hour Holter monitoring • Echocardiography Treatment initiation Detailed cardiac evaluation should be carried out ideally within 48 hours after initiation of treatment: • ECG • 24–48-hour Holter monitoring • Echocardiography During dose titration Periodic ECG: • Every 2 years or more frequently if considered necessary Detailed cardiac evaluation should be carried out before and after any dose increase: • ECG • 24–48-hour Holter monitoring • Echocardiography Maintenance therapy Detailed cardiac evaluation is recommended at least annually, or more frequently if considered necessary as part of routine cardiac assessment: • ECG • 24–48-hour Holter monitoring • Echocardiography Cardiac considerations1 Mexiletine may induce an arrhythmia or accentuate a pre-existing arrhythmia, either diagnosed or undiagnosed Please see the Summary of Product Characteristics and Healthcare Professional Educational Guide for more information For a full list of contraindications and drug interactions please see the Summary of Product Characteristics ECG, electrocardiogram

Alpharmaxim: World Alzheimer’s Day campaign. (Social Media)

This video won a Viddy platinum award 2023.

AstraZeneca: CVRM Highlights Video. (Internal Social Media) CVRM Townhall 2024.

AstraZeneca: A Catalyst Manifesto (Internal Social Media) Internal Promotional video.

Alpharmaxim: International Med Comms Day. (Social Media)

Feel good video explaining the process of a creative project in a Med Comms Agency.

Motion and video projects.

A small selection of motion and video projects I have worked on for both AstraZeneca and Alpharmaxim.

WATCH VIDEO WATCH VIDEO WATCH VIDEO WATCH VIDEO

First blue Healthcare Your VR Therapy Landing page.

Initial branding and digital creative for supply to development team in XD.

Ex munere deserunt eloquentiam usu, ut sit aliquip epicuri suavitate cum impedit petentium in. Tincidunt adipiscing et sit, facilis sadipscing per ad, dolores complectitur nec et ius cibo dolores noluisse, ad eos alia repudiare. Ad fierent consetetur est, purto audiam similique ei est. Ut his quando vocibus fabellas no velit paulo commune vel, ut qui nisl oportere. LOREM IPSUM DOLOR SIT LOREM IPSUM SIT AMET LOREM IPSUM SIT AMET Ex munere deserunt eloquentiam usu, ut sit aliquip epicuri suavitate cum impedit petentium in. Tincidunt adipiscing et sit, facilis sadipscing per ad, dolores complectitur nec et ius cibo LOREM IPSUM Ex munere deserunt eloquentiam usu, ut sit aliquip epicuri suavitate cum impedit petentium in. Tincidunt adipiscing et sit, facilis sadipscing per ad, dolores complectitur nec et ius cibo LOREM IPSUM In eos accusamus evertitur philosophia, vis ad quodsi discere insolens, eum inani maluisset ei. Ut has hinc pericula, sea eu propriae singulis, ut magna legendos cum. No mel putent latine. Quaeque vivendo pertinax et eos, ne vel suas nobis nullam adipisci cu. Primis nostrud dissentias qui cu, viris torquatos omittantur in sit, corrumpit honestatis accommodare. Summo novum adipiscing cu pro, no vis homero forensibus. Scripta sanctus cu his, per et probo porro. Ubique mentitum luptatum ad pri, est in lorem phaedrum erat recteque elaboraret. Ad cum novum virtute, ad enim legendos duo, delenit MENU VR Therapy for mental health, dementia and home therapy Ex munere deserunt eloquentiam usu sit aliquip epicuri suavitate cum impedit petentium in reque zril sit ei. Tincidunt adipiscing et sit facilis sadipscing per ad dolores complectitur nec et. ©Your VR Therapy 2023 Terms Privacy Links LOREM IPSUM DOLOR Organization E-mail Let us know how we can help SEND MESSAGE impedit petentium in. Tincidunt adipiscing et sit, facilis sadipscing per ad, dolores complectitur nec et ius cibo Ex munere deserunt eloquentiam usu, ut sit aliquip epicuri suavitate cum impedit petentium in. Tincidunt adipiscing et sit, facilis sadipscing per ad, dolores complectitur nec et ius cibo dolores noluisse, ad eos alia repudiare. Ad fierent consetetur est, purto audiam similique ei est. Ut his quando vocibus fabellas no velit paulo commune vel, ut qui nisl oportere. LOREM IPSUM DOLOR SIT LOREM IPSUM SIT AMET impedit petentium in. Tincidunt adipiscing et sit, facilis sadipscing per ad, dolores complectitur nec et ius cibo ad, dolores complectitur nec et ius cibo READ MORE Ex munere deserunt eloquentiam usu sit aliquip epicuri suavitate cum impedit petentium in reque zril sit ei. Tincidunt adipiscing et sit facilis sadipscing per ad dolores complectitur nec et. ©Your VR Therapy 2023 Terms Privacy Links LOREM IPSUM DOLOR Full name Organization E-mail Let us know how we can help Phone SEND MESSAGE VR Therapy for mental health, dementia and home therapy In eos accusamus evertitur philosophia, vis ad quodsi discere insolens, eum inani maluisset ei. Ut has

First blue Healthcare Recruitment creative. Flat carousel posts.

LiQuid. (Next-GEN 360)

Promotional Autumn 2021 campaign for Nic Salts E-liquid.

Some say the 80’s was one of the best decades for music. They also brought us the Peugeot 205, winning ‘What car?’ of the year in 1984. What did you or your parents drive back in the 80’s? (some also say if you can remember the 80’s, you weren’t there... just ask Guns ‘n’ Roses).

The 90’s brought us every boy racer’s dream, the BMW E36 M3 available in coupé, sedan and convertible body styles. Were you ‘mad for it’ in the 90’s? Were you a rocker, a raver or even a shoegazer, what did you drive?

The ‘noughties’ may not seem that long ago, with girl bands at their peak and Craig David walking away, the Volkswagen Golf MKIV entered the fray. Do you remember the ad ‘why drive something like a Golf, when you can drive a Golf?’ Do you own one and do you love them or not?

wedelivercars.co.uk Social brand engagement campaign 2021. Creative and content.

We don’t just deliver cars, we love everything about them! Can you remember the name of the car from this famous TV series? We want the name of the car remember, not the series! Play ‘Can you name that TV car in one? every Friday

of France, gone a little crazy and even fallen head over heels. Can you name the lovable character? Extra points if you can name every

Some of you won’t remember this action comedy that ran from 1979 to 1985, but we can guarantee it was a family favourite ranking second only to Dallas! Can you tell us what the Duke boys called their car? There’s one extra point for every Duke family member you can name.

wedelivercars.co.uk

Social brand engagement campaign 2021. Creative and content.

wedelivercars.co.uk

Website, customer booking form and CRM integration into Active Campaign 2020.

PRINTED ADVERT CAMPAIGN :

A4 printed adverts for Optician’s magazine both printed and digital. Ad’s feature unique QR codes with tracking codes to collate data from both printed and digital publications in Pardot CMS.

RICHARD DONOVAN

Creative digital design

E-SHOT:

E-shot created in Beefree, integrated with Pardot CMS to follow up collected data from printed and digital advertising.

sOCIAL:

Content and imagery re-purposed for campaign on facebook, linkedin and Instagram.

WEB ADVERTISING BANNERS :

Animated gifs created for landing pages for the Oil and Gas industry featuring the key messages from the campaign.

RILEY - PERFORMANCE EYEWEAR
GIVING YOU A CLEAR PERSPECTIVE
A contemporary range of sports and classic frame styles
All lenses impact tested to 45 m/s or 100mph • 10 times more impact resistant than plastic or glass lenses (EN166 - Grade F) • Digital free form varifocals fitted as standard
Increased strength range of +/- 12.00 on R104 frame • Heightened optical quality • Class 1 optical clarity
100% protection from the sun’s harmful UV rays
Lightweight & scratch resistant
Max turnaround of 10 working days MADE IN UK The Riley® performance safety eyewear range incorporates a full portfolio of prescription RX models, all expertly manufactured and delivered efficiently via our UK-based eyecare laboratory. All our prescription safety glasses feature robust polycarbonate lenses as standard to EN166 F. Scan QR code with phone camera for a FREE product sample. GROUP Part of WHAT REALLY SETS RILEY RX APART? https://www2.globusgroup. com/rileyrx

RICHARD DONOVAN

PRODUCT CAMPAIGN:

Another light hearted social media campaign to raiseGlobus Group’s progression over the decades using the concept: ‘Have you seen our products on the telly?

- Just like Globus Group, things have progressed.

Platform: Linkedin

GLOBUS GROUP Creative digital design

Art direction/CONTENT creation

ONE OFF POSTS:

A mix of flat posts under the Globus Group banner:

Platform: Linkedin

social posts
GLOBUS GROUP

PRODUCT LAUNCH CAMPAIGN

THE BRIEF:

To provide creative support to aid the launch of the C.K Magma Pro Tool Case Plus primarily designed for professional electricians. The leading USP of this product is the fact that it features multiple vertical storage pockets, offering easy access to tools and perfect organisation.

“A PLACE FOR EVERY TOOL AND EVERY TOOL IN IT’S PLACE”

The product is to launch online, through our UK and International Sales Teams and through social media, with an estimated revenue of 189k over two years. Sectors include: Commercial, domestic and Industrial.

MARKETING REQUIREMENTS:

International packaging, product and in-use photography, International sales collateral, wordpress web page, promotional video and social media campaign.

Creative direction:

Briefing our photographer based in Dorset. Sourcing models and shoot locations. Shots are required as in-use, for packaging, promotional materials and social media.

C.K MAGMA PRO TOOL CASE PLUS 2019 LAUNCH CAMPAIGN

Industrial photography :

The Pro Tool Case Plus in-situ in an industrial location. This will also be chosen for the cover of a printed trade promotion aimed at the Electrical and Industrial sector, ‘Fusion’.

Consumer video:

The brief required something different, to create disturbance in the product field, but still stay true to the ‘every tool’ strap line. To break the format of current storage videos seen in the market place. The concept evolved into a stop motion scene where an electrician calls his tools to take their place in the case after he had finished his job.

Please have a look at the video, we’re very proud of it!

Creative digital design

Promotional sales collateral design :

In-house product photography of features and benefits in focus, created in English, German, Spanish and French.

A4 printed 50,000. Mobile e- campaign to trade using a database of 24,000, monitoring click through rates and demographics.

RICHARD DONOVAN C.K MAGMA ❙ 03
ProToolCasePlus MA2640››
Dualsideopeningstorage
Multipleverticalstorage pockets
Perfectorganisation
100%waterproofbase £43NETTEACH.29 Toolsnotincluded NEW 1STFEBRUARY–21STJUNE2019 MARKYOURORDER FUS19 NOMINIMUMORDERQTY “APLACEFOR EVERYTOOL ANDEVERYTOOL INIT’SPLACE” WERKZEUGTASCHE PRO PLUS MA2640 450 X 290 X 340 MM 2,65 KG NEU ZÖGERN SIE NICHT, BESTELLEN SIE JETZT! T: +49 (0) 202 89030 F: +49 (0) 202 890322 MEHR ALS 60 TASCHEN UND HALTER MIT ÜBERSICHTLICHER ANORDNUNG 100% WASSERDICHT UND BRUCHSICHER DURCH GUMMIERTEN BODEN 3 4 BEIDSEITIGE AUFBEWAHRUNG MIT BREITER ÖFFNUNG HOCH WIDERSTANDSFÄHIGE GEGEN EINDRINGEN VON SPITZEN GEGENSTÄNDEN GESCHÜTZTE REISSVERSCHLÜSSE 1 2 EIN PLATZ FÜR JEDES WERKZEUG UND JEDES WERKZEUG AN SEINEM PLATZ. DIE WERKZEUGTASCHE PRO PLUS IST DIE BESTGEEIGNETE TASCHE FÜR DIE ORGANISATION UND DEN SCHUTZ IHRER WERKZEUGE! IHRE ZAHLREICHEN SENKRECHTEN ABLAGEFÄCHER BIETEN LEICHTEN ZUGANG ZU DEN WERKZEUGEN UND PERFEKTE ORGANISATION FÜR IHRE WERKZEUGTASCHE.
WATCH VIDEO

DIGITAL AND PRESS AD CAMPAIGN (creative) :

Design of impactful adverts to convey the benefit of SPIRA-FLEX based on the ‘REACH FURTHER’ strap line.

Consumer video:

The brief required the draw tapes to be shot in an industrial location highlighting the benefits of a SPIRA-FLEX draw tape vs standard steel and nylon draw tapes.

We built a perspex run, to show how the flexible draw tape handled corners and tight turns. This was then highlighted with animation for the key points.

RICHARD DONOVAN

Creative digital design

Promotional sales collateral design :

A4 landscape Pixsell presenter of features and benefits in focus, created in English, German, Spanish and French.

Mobile e-campaign to trade using a database of 24,000, monitoring click through rates and demographics.

C.K TOOLS
www.ck-tools.com Eliciis intemqui des re molorro incid escia qui aut mo et omnimusam conem quae est, tem idus re, unt volor rerspistotae nias quassimo cuptatu Bearum que nectatem es volorrovid ma nistium aliquis dolore versperit que sime dolorro delest liquis molorro dusapid quos ne accuptatus comnienim hilibus dolorrum experes delluptum es int faccullaut ipsunt qui nonsedit, sit que etur, ipicia ditatem. Um quaspiendus dolest, cus es ereiust. NEXT GEN ADVANCED TECHNOLOGY REACH FURTHER NEXT GEN ADVANCED TECHNOLOGY Designed for longer, smoother, quicker cable installations, the innovative NEW C.K SPIRA-FLEX draw tape is a major advancement in draw tape technology. Made from an advanced polyethylene terephthalate (PET) material with a helical profile, SPIRA-FLEX significantly reduces frictional resistance and minimises snagging. Available in 10m, 20m and 30m lengths. www.ck-tools.com NEW To see the Spira-Flex Draw Tape in action visit www.youtube/CKtoolsTV www.ck-tools.com Eliciis intemqui des re molorro incid escia qui aut mo et omnimusam conem quae est, tem idus re, unt volor rerspistotae nias quassimo. Bearum que nectatem es volorrovid ma nistium aliquis dolore versperit que sime dolorro delest liquis molorro dusapid quos ne accuptatus comnienim hilibus dolorrum experes delluptu. Bearum que nectatem es volorrovid ma nistium aliquis dolore versperit que sime dolorro delest liquis molorro dusapid quos ne accuptatus comnienim hilibus dolorrum experes delluptu. NEXT GEN ADVANCED TECHNOLOGY FLEX draw tape is a significant improvement on standard nylon DON'T WAIT! PLACE YOUR ORDER NOW! T: 01758 704 704 F: 01758 704 705 E: sales@cki.uk.com Features and benefits Innovative spiral design significantly reduces frictional resistance allowing for Manufactured from an advanced PET material super flexible and immensily tough Considerably less kinking and coiling compared to nylon NEW
WATCH VIDEO

QUANTUM TRADE AND CONSUMER PROMOTION

TRADE AND CONSUMER PROMOTION

Gripper Gloves

Provide protection for all manual handling tasks. Non-slip criss cross pattern provides grip in all conditions.

Rigger Gloves

Full palm cowhide split leather for durability. Lined palm for enhanced comfort. Rubberised cuff for increased wrist protection. Heat resistant up to 50°C.

THE BRIEF:

To build business development with Carl Kammerling international through a measured approach. The scheme provides access to new products, range deals, a price promotion and a consumer sell-out promotion.

Creative direction:

To provide a fresh look at new products and layout of the whole campaign. New product photography, in use photography and a fresh look at typography.

There is a light that never goes out...

CARL KAMMERLING INTERNATIONAL
MOQ 6 ITEM CODE SIZE NETT TRADE RRP INC VAT SSP INC VAT DISCOUNT MOQ AV13078 L £1.12 £2.99 £1.99 55.0% 6 AV13079 XL £1.12 £2.99 £1.99 55.0% 6
NETT EACH £1.12
NETT EACH £1.76 MOQ 6 NETT EACH £33.76 MOQ 6
WIGIG High power rechargeable LED flood light featuring a strong clamp system and 360° swivel head. Supplied with Mains charger. 1 2 3 4

THE BRIEF:

To re-fresh a range of packaging including the C.K Dextro VDE Slim Glo Screwdriver set. The design should stand out on fixture, with clear messages to engage the end user. Packaging is to be translated into French, German and Spanish.

To support the launch, a press and social media campaign is required to raise awareness, create desire and increase social engagement.

MADE I N GERMAN Y MADE I N GERMAN Y MADE I N GERMAN Y phosphorescent slim VDE screwdrivers VDE-Schraubendreher phosphoreszierend, mit Klingen mit schlankem Scha tourne is phospho escents isolés VDE à la e fine ph pho t slim VDE screwdrivers phosphoreszierend, mit Klingen mit schlankem Scha is ph spho phosphorescent lim VDE screwdrivers phosphoreszierend, mit Klingen mit schlankem Scha designed for professionals www.ck-tools.com C.K is registered trademark of Carl Kammerling International Ltd DEXTRO VDE SLIM GLO PREMIUM QUALITY VDE SCREWDRIVERS 1 Precision machined tip for an exact screw fit & damage free screwdriving fixings 3 Premium quality Molybdenum-Vanadium steel blade for exceptional strength & durability VDE approved individually tested to 10,000v for safe live working up to 1,000v 5 Long fine neck for precise fingertip control 6 Handle injection moulded directly to blade giving the ultimate bond for increased reliability & durability Glow in the dark phosphorescent screwdrivers for greater visibility in low light conditions 8 Ergonomically shaped, dual component handle for increased comfort, control & safety 9 Ridges along the head give extra grip in that last ¼ turn 10 Tip type marking for easy identification DEXTRO VDE PREMIUM QUALITÄTS-SCHRAUBENDREHER 1 Präzise bearbeitete Spitze für exakte Anpassungen an die Schrauben und beschädigungsfreies Eindrehen 2 versenkten Schrauben und Befestigungen 3 4 Langer Hals für präzise Führung mit der Fingerspitze 6 7 Schraubendreher glimmen in der Dunkelheit – für bessere Sichtbarkeit 8 Ergonomisch geformt, 2-Komponentengriff für höheren Komfort, bessere Handhabung und Sicherheit 9 Erhebungen entlang des Kopfes bieten zusätzliche Griffigkeit in der letzten 1/4-Umdrehung Spitzen-Markierung zur einfachen Erkennung DEXTRO VDE SLIM GLO TOURNEVIS VDE DE QUALITÉ PREMIUM 1 Pointe usinée ec précision exactement adaptée à l’empreinte des vis pour un vissage sans détérioration 2 Lames isolées à tige fine, permettant d’accéder aux vis et fixations noyées 3 Lame en Acier Molybdène Vanadium d'excellente qualité pour une résistance et une longévité exceptionnelles 4 Homologués VDE testés individuellement à 10 000 V pour un travail en toute sécurité jusqu’à 1 000 V 5 Tige longue et fine pour la maîtrise précise au doigt. 6 Manche moulé par injection directement sur la lame assurant une adhérence optimale pour une fiabilité et une durabilité accrues. 7 Tournevis phosphorescents – pour une meilleure visibilité dans de faibles conditions d’éclairage 8 Manche ergonomique bicomposant pour un confort accru, maîtrise et sécurité 9 Rainures le long de la tête assurant une excellente prise en main au dernier quart de tour 10 Marquage du type sur la pointe pour faciliter l’identification Zugang Hochqualitativer Molybdän-Vanadium-Stahlscha mit außergewöhnlicher Festigkeit und Dauerha igkeit Dauerha igkeit T49283PD 5 PCS T49283PD PZD 1, 2 3.5 4.0 5.5mm PACKAGING PRINT AND DIGITAL
C.K TOOLS DEXTRO GLO SCREWDRIVERS

PRESS AD CAMPAIGN (creative) :

Examples of the press campaign featuring in house photography. Strong headline and copy, with image showing the Dextro Glo and featuring the new packaging. Mock ups awaiting final sign off.

Social media CONSUMER Push:

With video being the most consumed form of media on social platforms, an animated campaign is required to increase consumer engagement.

The ads need to be eye catching and suit the social media format, but need to be cost effective within the studio to create a campaign.

C.K TOOLS Creative digital design
RICHARD DONOVAN
CONTACT ME

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.